Birla Pacific Medspa Ltd
Birla Pacific Medspa Limited, incorporated in India, Listed on the Bombay Stock exchange Limited, the company is engaged in the business of medical, health care treatments.
- Market Cap ₹ Cr.
- Current Price ₹ 0.28
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 9.48
- Dividend Yield 0.00 %
- ROCE %
- ROE -1.77 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.03 times its book value
Cons
- Company has low interest coverage ratio.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | |
|---|---|
| 3.93 | |
| 5.96 | |
| Operating Profit | -2.03 |
| OPM % | -51.65% |
| 1.30 | |
| Interest | 0.03 |
| Depreciation | 1.12 |
| Profit before tax | -1.88 |
| Tax % | 0.00% |
| -1.88 | |
| EPS in Rs | -0.17 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | |
|---|---|
| Equity Capital | 112.14 |
| Reserves | -5.83 |
| 0.16 | |
| 1.43 | |
| Total Liabilities | 107.90 |
| 5.44 | |
| CWIP | 0.00 |
| Investments | 1.90 |
| 100.56 | |
| Total Assets | 107.90 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | |
|---|---|
| 14.25 | |
| -77.07 | |
| 64.99 | |
| Net Cash Flow | 2.17 |
| Free Cash Flow | -40.67 |
| CFO/OP | -707% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2012 | |
|---|---|
| Debtor Days | 1.86 |
| Inventory Days | 114.51 |
| Days Payable | 622.65 |
| Cash Conversion Cycle | -506.28 |
| Working Capital Days | 2,020.04 |
| ROCE % |
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 9 May 2017
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 31 Mar 2017
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 17 May 2016
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 16 May 2016
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 17 Mar 2016